HistoCyte™ – The Issue with Tissue

Laboratories are dependent on using the tissue that they produce as the control for subsequent tests performed. Tissues, or more specifically the biomarkers of interest, are subject to preanalytical variations such as cold ischemic time and formalin fixation times.1 These, in combination with the actual processing of the tissue, are known to affect the quality […]

Asuragen – QuantideX ESR1 exoMutation Kit

ESR1 Mutations are the Leading Cause of Primary Treatment Resistance in HR+ mBC ESR1 gene codes for estrogen receptor alpha (ERα), and mutations in its ligand-binding domain trigger constant activation of the receptor, leading to excessive downstream signalling.

HistoCyte – Lung Cancer controls

Gaining over 15,000 cases this 2024 and leading with the lowest survival rate for cancer types, lung cancer has been in the forefront of cancer cases in Australia. Biomarkers such ALK, ROS1, PD-L1, and BRAF are used in IHC and molecular laboratory techniques to identify specific types of lung cancer and guide targeted therapy.

HistoCyte – ER/PR/HER2/PDL1 controls

HistoCyte tissue controls are a testament to precision and reliability in the diagnosis of breast cancer.

Asuragen – QuantideX BCR-ABL

Asuragen’s Precision Oncology Solutions. Revolutionising Precision Oncology with QuantideX®: Where Sensitivity Meets Scalability

Flow Cytometry Validated Antibodies

Products are for professional/laboratory use only. For 50 years, Bethyl has served the immunoassays community with high quality antibodies validated for applications like IHC, IP, WB and ICC.